Well Referenced

Tag: IL-2

Soypeptide Lunasin in Cytokine Immunotherapy for Lymphoma

This 2014 study investigates the synergistic effects of the soybean-derived peptide lunasin combined with cytokines IL-2 and IL-12 on natural killer (NK) cells in the context of lymphoma immunotherapy. Lunasin enhances NK cell activation, increasing the expression of IFNγ and granzyme B, leading to improved cytotoxicity against lymphoma cells. Notably,

Read More »
June 26, 2025 No Comments

Intravenous Ascorbic Acid as an Adjuvant to Interleukin-2 Immunotherapy

This 2014 study investigates the potential synergistic effects of combining high-dose intravenous ascorbic acid (vitamin C) with interleukin-2 (IL-2) immunotherapy in cancer treatment. The authors discuss how ascorbic acid may enhance the efficacy of IL-2 by modulating immune responses, reducing oxidative stress, and improving patient tolerance to therapy. Preliminary findings

Read More »
June 26, 2025 No Comments